Futura Medical plc (FAMDF)
Other OTC - Other OTC Delayed price. Currency in USD
Add to watchlist
At close: 11:56AM EST
| Previous close | 0.4200 |
| Open | 0.4200 |
| Bid | 0.0000 x 0 |
| Ask | 0.0000 x 0 |
| Day's range | 0.4200 - 0.4200 |
| 52-week range | 0.3200 - 1.0000 |
| Volume | |
| Avg. volume | 1,360 |
| Market cap | 189.171M |
| Beta (5Y monthly) | 1.82 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | -0.0220 |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- Simply Wall St.
Will Futura Medical (LON:FUM) Spend Its Cash Wisely?
We can readily understand why investors are attracted to unprofitable companies. For example, although Amazon.com made...
- Simply Wall St.
Futura Medical plc (LON:FUM) is favoured by institutional owners who hold 63% of the company
A look at the shareholders of Futura Medical plc ( LON:FUM ) can tell us which group is most powerful. We can see that...
- Business Wire
Highly positive FM71 Phase 3 study results with all primary and secondary endpoints achieved, MED3000 remains on track to submit for FDA marketing authorization
GUILDFORD, England, August 31, 2022--Futura Medical plc (AIM: FUM), a pharmaceutical company developing a portfolio of innovative products based on its proprietary, transdermal DermaSys® drug delivery technology and currently focused on sexual health and pain, today announces positive results from the confirmatory Phase 3 clinical study, "FM71" for MED3000, an investigational therapy for the treatment of erectile dysfunction ("ED").
© 2023 Yahoo. All rights reserved.
